| |
|
|
 |
- Address:
- 3005 First Avenue
Seattle, WA 98121
- Phone:
- (206) 256-4545
- Website:
- http://www.dendreon.com
-
- Company Information:
-
Dendreon Corp., is located at Seattle, WA and is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Through innovative science and technology, we are striving to develop and commercialize products that address unmet medical need, improve survival and have a favorable safety profile. Our active immunotherapy, monoclonal antibody and small molecule development capabilities provide us with a solid foundation on which to build a variety of oncology treatments that meet these objectives.
In addition to product candidates in clinical trials, we have a broad preclinical pipeline of active immunotherapies, monoclonal antibody and small molecule targets. These include compounds targeted to Trp-p8, a protein expressed on the surface of several types of cancer cells. Trp-p8 therapeutics are being developed in collaboration with Genentech, Inc., and additional preclinical programs are the subject of collaborations with Abgenix, Inc. and Dyax Corp.
Everyone at Dendreon is aware of the importance of our work to the millions of lives touched by cancer worldwide, and this knowledge motivates us to strive for excellence in everything we do.
|
 |
|
|
